The Gila Monster: A Remarkable Contributor to Modern Medicine
It may seem like a scene from a horror movie: a poisonous and slow-moving creature that spends most of its life hidden beneath the sands of the desert. Yet, this reptile, far from being a threat, has emerged as one of the significant protagonists of modern medicine. Its name is Heloderma suspectum, better known as the Gila Monster . The unique properties of its venom have inspired medications recently hailed as tools for weight loss.
An Unexpected Finding
In 1980 , gastroenterologist Jean-Pierre Raufman was intrigued by the therapeutic potential of natural substances. His research focused on a variety of animal venoms. Captivated by the Gila Monster, which inhabits the arid regions of the southern United States and northern Mexico , Raufman noted its remarkable survival skills, spending 98% of its life in underground burrows and requiring only six meals a year, thanks to the fat stored in its tail—similar to how camels function.
According to a report by BBC, Raufman’s interest was piqued further when chemist John Pisano provided a sample of Gila Monster venom in search of new peptide-type molecules . Endocrinologist John Eng later resumed this line of research, successfully isolating two significant molecules from the venom: Exendin-3 and Exendin-4 . These molecules exhibited behavior similar to a human hormone known as LPG-1 , which plays a critical role in regulating insulin production, thus paving the way for innovative drugs.
The Science Behind LPG-1
So how did a poison from a desert-dwelling creature become the star of weight loss medications? The Gila Monster-4 peptide mimicked the action of LPG-1 but brought a crucial advantage: it lingered longer in the human body, thus sustaining its effects on metabolism . This led to the development of innovative drugs like Byetta (exenatide), intended for individuals with Type 2 diabetes.
As explained in detail by BBC, these advancements have culminated in well-known medications like Ozempic , Wegovy , and Mounjaro . Beyond merely regulating blood sugar levels, these drugs also reduce appetite, resulting in noticeable weight loss by targeting brain receptors responsible for hunger. The secret lay in a minor alteration of the molecule; by adding certain fatty acid chains , they transformed the drug into a form that remained in the bloodstream longer, leading to more consistent therapeutic effects.
A Major Problem Awaits
However, the Gila Monster faces a critical problem : the shrinking of its habitat. According to a study published in Ecology and Evolution , Gila Monsters are witnessing a drastic reduction in their range due to climate change and habitat fragmentation. By 2070 , experts estimate that large portions of their current territory, particularly in regions like the Mojave Desert , may become uninhabitable, pushing these unique reptiles even further towards extinction.
The Poison as a Pathway for Research
The application of toxic compounds in medicine isn’t entirely new. For instance, captopril , commonly prescribed for hypertension, is derived from the venom of the Brazilian snake, Bothrops jararaca . Today, this principle is being explored on a genetic level. Hungarian researcher Zoltan Takacs is engaged in a project to catalog various animal toxins, establishing a comprehensive database that serves as a foundation for developing new pharmacological treatments.
Hidden Underground
The journey of the Gila Monster serves as a reminder that some of the most profound scientific secrets lie hidden beneath the sand. Today, the reptile’s survival hinges on human efforts. Although laboratories extract invaluable wisdom from its venom, the Gila Monster’s natural habitat diminishes, and its existence becomes increasingly fragile. The next groundbreaking advancement in science could emerge from our efforts to understand and protect this extraordinary creature.
Image credits: Unsplash and Unsplash.
Xataka has featured personal stories like, “I lost 55 kilos but regained 30 after stopping Ozempic,” where Spanish individuals share their roller-coaster experiences with the medication.